✦ LIBER ✦

A Phase 1 Study of a Vaccine Targeting Preferentially Expressed Antigen in Melanoma and Prostate-specific Membrane Antigen in Patients With Advanced Solid Tumors :

✍ Scribed by Weber, Jeffrey S.; Vogelzang, Nicholas J.; Ernstoff, Marc S.; Goodman, Oscar B.; Cranmer, Lee D.; Marshall, John L.; Miles, Sabrina; Rosario, Dar; Diamond, David C.; Qiu, Zhiyong

Book ID: 111672704
Publisher: Lippincott Williams and Wilkins
Year: 2011
Tongue: English
Weight: 522 KB
Volume: 34
Category: Article
ISSN: 1053-8550
DOI: 10.1097/cji.0b013e3182280db1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I trial of DNA vaccination with

A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer

✍ Pavlenko, M; Roos, A-K; Lundqvist, A; Palmborg, A; Miller, A M; Ozenci, V; Bergm 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 135 KB

A phase I dose escalation trial of vacci

A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in subjects with prostate cancer

✍ Slovin, Susan F.; Kehoe, Marissa; Durso, Robert; Fernandez, Celina; Olson, Willi 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 726 KB

A vaccine capable of eliciting an antitu

A vaccine capable of eliciting an antitumor response for prostate tumors; prostate-specific antigen, prostate-specific membrane antigen or prostate acid phosphatase gene cloning and expression for use as a recombinant vaccine or in genetic immunization : Jenner Technol. World 9504 548; 16 February 1995

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Phase I Trial of 177Lutetium-Labeled J59

Phase I Trial of 177Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer

✍ Walsh, Patrick C. 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 52 KB

Phase 1 pharmacokinetic and drug-interac

Phase 1 pharmacokinetic and drug-interaction study of dasatinib in patients with advanced solid tumors

✍ Faye M. Johnson; Shruti Agrawal; Howard Burris; Lee Rosen; Navneet Dhillon; Davi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB 👁 1 views

Phase I Safety and Pharmacokinetic Study

Phase I Safety and Pharmacokinetic Study of Bavituximab, a Chimeric Phosphatidylserine-Targeting Monoclonal Antibody, in Patients with Advanced Solid Tumors

✍ Gerber, D. E.; Stopeck, A. T.; Wong, L.; Rosen, L. S.; Thorpe, P. E.; Shan, J. S 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 346 KB